Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from AngioDynamics ( (ANGO) ) is now available.
On April 23, 2026, AngioDynamics, Inc. filed a patent infringement lawsuit in the U.S. District Court for the District of Delaware against Endovascular Engineering, Inc., alleging that E2’s Hēlo Thrombectomy System unlawfully incorporates features covered by AngioDynamics’ patents, including its proprietary self-expanding funnel technology used to enhance removal of thrombi and emboli. The company is seeking damages and equitable relief, underscoring its strategy of actively defending core intellectual property to safeguard its thrombectomy franchise, support ongoing innovation in clot-removal technologies and reinforce its competitive position in the vascular intervention market.
The most recent analyst rating on (ANGO) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on AngioDynamics stock, see the ANGO Stock Forecast page.
Spark’s Take on ANGO Stock
According to Spark, TipRanks’ AI Analyst, ANGO is a Neutral.
The score is driven primarily by solid financial resilience (debt-free balance sheet, stable gross margins) but restrained by ongoing operating losses and inconsistent free cash flow. The latest earnings call is a meaningful positive due to raised FY2026 guidance and strong Med Tech platform momentum, while technicals are mixed-to-weak with the stock trading below major moving averages. Valuation is less supportive given negative earnings and no dividend yield provided.
To see Spark’s full report on ANGO stock, click here.
More about AngioDynamics
AngioDynamics, Inc. is a medical technology company that develops and markets minimally invasive devices used in vascular, peripheral and other interventional procedures. Its portfolio includes thrombectomy and emboli-removal systems that target the treatment of blood clots and related conditions in hospitals and other care settings.
Average Trading Volume: 443,163
Technical Sentiment Signal: Sell
Current Market Cap: $442.9M
Learn more about ANGO stock on TipRanks’ Stock Analysis page.